Source: Oral Oncology. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, FATORES DE RISCO, NEOPLASIAS DE CABEÇA E PESCOÇO
ABNT
OLIVIERI, Eloisa Helena Ribeiro et al. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncology, v. 45, n. 9, p. I, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2009.03.004. Acesso em: 28 abr. 2024.APA
Olivieri, E. H. R., Silva, S. D. da, Mendonça, F. F., Urata, Y. N., Vidal, D. O., Faria, M. de A. M., et al. (2009). CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncology, 45( 9), I. doi:10.1016/j.oraloncology.2009.03.004NLM
Olivieri EHR, Silva SD da, Mendonça FF, Urata YN, Vidal DO, Faria M de AM, Nishimoto IN, Rainho CA, Kowalski LP, Rogatto SR. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients [Internet]. Oral Oncology. 2009 ; 45( 9): I.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.oraloncology.2009.03.004Vancouver
Olivieri EHR, Silva SD da, Mendonça FF, Urata YN, Vidal DO, Faria M de AM, Nishimoto IN, Rainho CA, Kowalski LP, Rogatto SR. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients [Internet]. Oral Oncology. 2009 ; 45( 9): I.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.oraloncology.2009.03.004